The angiotensin II type 2 receptor in the brain

被引:31
作者
Horiuchi, Masatsugu [1 ]
Mogi, Masaki [1 ]
Iwai, Masaru [1 ]
机构
[1] Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime 7910295, Japan
关键词
angiotensin; AT(2) receptor; brain; cognitive function; stroke; MARROW STROMAL CELLS; GROWTH-FACTOR PRODUCTION; MESENCHYMAL STEM-CELLS; AT(2) RECEPTOR; AT2; RECEPTOR; FUNCTIONAL RECOVERY; CONTAINING PROTEIN-TYROSINE-PHOSPHATASE-1; NEURONAL DIFFERENTIATION; INTERACTING PROTEIN; NEURITE OUTGROWTH;
D O I
10.1177/1470320309347793
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Recent clinical studies indicate that blockade of the renin-angiotensin system is important to prevent stroke, and accumulating results of basic research also indicate the possible involvement of the central renin-angiotensin system in ischaemic brain damage and cognition. When the angiotensin II type 1 receptor is blocked by an angiotensin type 1 receptor blocker, unbound angiotensin II acts preferentially on the angiotensin II type 2 (AT(2)) receptor. These results suggest the pathophysiological importance of the AT(2) receptor in the clinical use of angiotensin type 1 receptor blockers, which are widely used in patients with hypertension with the expectation of a decrease in the onset of cardiovascular and cerebrovascular disease. We review here the possible roles of AT(2) receptor activation in the brain, focusing on ischaemic stroke, cognitive function and neurogenesis, and potential effects of specific AT(2) receptor agonists.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 55 条
[41]   Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo:: role of the AT2 receptor and the transcription factor NF-κB [J].
Reinecke, K ;
Lucius, R ;
Reinecke, A ;
Rickert, U ;
Herdegen, T ;
Unger, T .
FASEB JOURNAL, 2003, 17 (12) :2094-+
[42]   Using bone marrow stromal cells for treatment of stroke [J].
Rempe, DA ;
Kent, TA .
NEUROLOGY, 2002, 59 (04) :486-487
[43]   Progress in secondary prevention of stroke with PROGRESS [J].
Schiffrin, EL .
CURRENT HYPERTENSION REPORTS, 2002, 4 (01) :39-40
[44]   Identification of a new tumor suppressor gene located at chromosome 8p21.3-22 [J].
Seibold, S ;
Rudroff, C ;
Weber, M ;
Galle, J ;
Wanner, C ;
Marx, M .
FASEB JOURNAL, 2003, 17 (06) :1180-+
[45]   The AT2 receptor - A matter of love and hate [J].
Steckelings, UM ;
Kaschina, E ;
Unger, T .
PEPTIDES, 2005, 26 (08) :1401-1409
[46]   NERVE GROWTH-FACTOR STIMULATES TYROSINE PHOSPHORYLATION AND ACTIVATION OF SRC HOMOLOGY-CONTAINING PROTEIN-TYROSINE-PHOSPHATASE-1 IN PC12 CELLS [J].
VAMBUTAS, V ;
KAPLAN, DR ;
SELLS, MA ;
CHERNOFF, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (43) :25629-25633
[47]   Molecular insights into polyubiquitin chain assembly: Crystal structure of the Mms2/Ubc13 heterodimer [J].
VanDemark, AP ;
Hofmann, RM ;
Tsui, C ;
Pickart, CM ;
Wolberger, C .
CELL, 2001, 105 (06) :711-720
[48]  
Vervoort VS, 2002, SCIENCE, V296, P2401
[49]   Ischemic injury in experimental stroke depends on angiotensin II [J].
Walther, T ;
Olah, L ;
Harms, C ;
Maul, B ;
Bader, M ;
Hörtnagl, H ;
Schultheiss, HP ;
Mies, G .
FASEB JOURNAL, 2002, 16 (02) :169-176
[50]   Intravenous versus intrastriatal cord blood administration in a rodent model of stroke [J].
Willing, AE ;
Lixian, J ;
Milliken, M ;
Poulos, S ;
Zigova, T ;
Song, S ;
Hart, C ;
Sanchez-Ramos, J ;
Sanberg, PR .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 73 (03) :296-307